CN112402335A - 一种爆水散粉及其制备方法 - Google Patents
一种爆水散粉及其制备方法 Download PDFInfo
- Publication number
- CN112402335A CN112402335A CN202011296342.4A CN202011296342A CN112402335A CN 112402335 A CN112402335 A CN 112402335A CN 202011296342 A CN202011296342 A CN 202011296342A CN 112402335 A CN112402335 A CN 112402335A
- Authority
- CN
- China
- Prior art keywords
- stirring
- phase
- water
- time
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 66
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 84
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000001140 aloe barbadensis leaf extract Substances 0.000 claims abstract description 13
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 12
- 239000002253 acid Substances 0.000 claims abstract description 12
- 238000000855 fermentation Methods 0.000 claims abstract description 11
- 230000004151 fermentation Effects 0.000 claims abstract description 11
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 10
- 241000235346 Schizosaccharomyces Species 0.000 claims abstract description 10
- 229940087068 glyceryl caprylate Drugs 0.000 claims abstract description 10
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 9
- 229940069638 aloe vera leaf extract Drugs 0.000 claims abstract description 9
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 9
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 9
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 claims abstract description 8
- 244000042430 Rhodiola rosea Species 0.000 claims abstract description 8
- 235000003713 Rhodiola rosea Nutrition 0.000 claims abstract description 8
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 2
- 239000002994 raw material Substances 0.000 claims description 62
- 238000003756 stirring Methods 0.000 claims description 58
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 34
- 238000002156 mixing Methods 0.000 claims description 32
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 28
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 17
- -1 polydimethylsiloxane Polymers 0.000 claims description 15
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 14
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 14
- 238000009775 high-speed stirring Methods 0.000 claims description 14
- 229960005323 phenoxyethanol Drugs 0.000 claims description 14
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 claims description 14
- 239000000377 silicon dioxide Substances 0.000 claims description 14
- 229960003966 nicotinamide Drugs 0.000 claims description 11
- 235000005152 nicotinamide Nutrition 0.000 claims description 11
- 239000011570 nicotinamide Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 claims description 7
- 241000378467 Melaleuca Species 0.000 claims description 7
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 claims description 7
- RWAXQWRDVUOOGG-UHFFFAOYSA-N N,2,3-Trimethyl-2-(1-methylethyl)butanamide Chemical compound CNC(=O)C(C)(C(C)C)C(C)C RWAXQWRDVUOOGG-UHFFFAOYSA-N 0.000 claims description 7
- 229920006037 cross link polymer Polymers 0.000 claims description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 7
- 229930007503 menthone Natural products 0.000 claims description 7
- 229940089508 methyl diisopropyl propionamide Drugs 0.000 claims description 7
- 239000011812 mixed powder Substances 0.000 claims description 7
- KERBAAIBDHEFDD-UHFFFAOYSA-N n-ethylformamide Chemical compound CCNC=O KERBAAIBDHEFDD-UHFFFAOYSA-N 0.000 claims description 7
- CFJYNSNXFXLKNS-UHFFFAOYSA-N p-menthane Chemical compound CC(C)C1CCC(C)CC1 CFJYNSNXFXLKNS-UHFFFAOYSA-N 0.000 claims description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 7
- 238000003860 storage Methods 0.000 claims description 7
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 7
- 229920002554 vinyl polymer Polymers 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 26
- 230000002087 whitening effect Effects 0.000 abstract description 7
- 230000003712 anti-aging effect Effects 0.000 abstract description 6
- 239000006166 lysate Substances 0.000 abstract description 3
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 241000521581 Millettia Species 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 description 27
- 210000003491 skin Anatomy 0.000 description 26
- 241000736199 Paeonia Species 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 230000003020 moisturizing effect Effects 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000032683 aging Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 239000002360 explosive Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 230000033616 DNA repair Effects 0.000 description 2
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000005422 blasting Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 229910001447 ferric ion Inorganic materials 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002390 cell membrane structure Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229910001448 ferrous ion Inorganic materials 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
本发明公开一种爆水散粉及其制备方法,通过加入水、甘油、1,2‑己二醇、辛酰羟肟酸、甘油辛酸酯,改善散粉的锁水和保湿功能,使更持久、柔滑细致;另外加入库拉索芦荟叶提取物、芍药根、透明质酸钠、二裂酵母发酵产物溶胞物、密罗木叶提取物、烟酰胺、红景天提取物等成分,提高肌肤免疫能力,具有美白、抗衰老的功效,达到完善肌肤护理效果。
Description
技术领域
本发明涉及散粉化妆品,尤其涉及一种爆水散粉及其制备方法。
背景技术
散粉是今年来广泛使用的面部化妆品,主要的作用是定妆,当彩妆随时间和油脂分泌而滑落,眼底、脸颊就会出现眼影、腮红的斑痕,从而影响彩妆效果,而散粉具有吸收面部多余油脂、减少面部油光的作用,可令彩妆更持久、柔滑细致,此外还有遮盖脸上瑕疵的功效。但现有散粉通常为固态粉末,质地不够细腻,且感觉不够水润贴服,还容易导致妆容变厚。
综上所述,如何提供一种含有水分和抗衰老,抗氧化作用的爆水散粉是本领域技术人员亟待解决的问题。
发明内容
本发明要解决的技术问题是针对现有技术的缺陷,提出一种含义水分和抗衰老,抗氧化作用的爆水散粉及其制备方法。
为解决上述技术问题,本发明采用如下技术方案:一种爆水散粉,其包括以下组分(按重量份计):
本发明还提供一种爆水散粉的制备方法,其特征在于包括以下步骤:
步骤一)第一次搅拌,按设定配比将A相原料:水、甘油、丙二醇、薄荷酮甘油缩酮、甲基二异丙基丙酰胺、薄荷烷甲酰乙胺、苯氧乙醇、乙基己基甘油充分搅拌溶解,静置待用;
步骤二)第二次搅拌:按设定配比将B相原料:1,2-己二醇、辛酰羟肟酸、甘油辛酸酯、甘油、水、苯氧乙醇、乙基己基甘油充分搅拌溶解,静置待用;
步骤三)第三次搅拌:按设定配比将C相原料:将库拉索芦荟叶提取物、芍药根提取物、透明质酸钠、二裂酵母发酵产物溶孢物、密罗木叶提取物、烟酰胺、红景天提取物充分搅拌溶解,静置待用;
步骤四)第四次搅拌:按设定配比将D相原料:聚甲基硅倍半氧烷、乙烯基聚二甲基硅氧烷/聚甲基硅氧烷硅倍半氧烷交联聚合物、甲硅烷基化硅石、硅石、聚甲基硅氧烷搅拌均匀,将第一次、第二次和第三次搅拌的混合料体加入进行混合,进行第五次高速搅拌;
步骤五)将混合好的粉料,放入料桶内,做好标示粉料存储间内,开启紫外线进行消毒灭菌储存,时间5-6小时。
优选地,在步骤一)中,所述A相原料需要加热至85℃后,以1000转/分钟进行充分搅拌至完全溶解,,然后冷却至室温静置待用。
优选地,在步骤二)中,所述B相原料以1000转/分钟混合搅拌至完全溶解,成透明状态。
优选地,在步骤三)中,述C相原料以1000转/分钟搅拌2分钟,搅拌至完全溶解。
优选地,在步骤五)中,第五次高速搅拌的时间为3-5秒,次数为2次,转速1000-3000转/分。
与现有技术相比,本发明通过添加水、甘油、1,2-己二醇、辛酰羟肟酸、甘油辛酸酯,来改善现有散粉比较干燥的缺陷,提高了保湿功效,令彩妆更自然、透明和柔和。
本发明还通过添加库拉索芦荟叶提取物,提高机体免疫能力,阻断大量自由基对肥大细胞和嗜碱粒细胞的氧化破坏,从而达到舒缓刺激的功效;加入二裂酵母发酵产物溶孢物、芍药根提取物,具有很强的抗免疫抑制活性并能促进DNA修复,可有效保护皮肤,可以加强角质层的代谢,还能捕获自由基,抑制脂质的过氧化,具有美白、抗衰老的功能;通过加入透明质酸钠,提高补水和保湿的效果;加入的烟酰胺可抑制已产生的黑色素,起到美白肌肤作用;综合而言,本发明保湿定妆、全面护理肌肤为导向而开发。
附图说明
图1为本发明一种爆水散粉的制备方法步骤图。
具体实施方式
下面将结合附图和具体的实施例,对本发明的技术方案进行详细说明。
本发明提供的一种爆水散粉,其包括以下组分(按重量份计):
本发明还提供一种爆水散粉的制备方法,其包括以下步骤:
步骤一)第一次搅拌,按设定配比将A相原料:水、甘油、丙二醇、薄荷酮甘油缩酮、甲基二异丙基丙酰胺、薄荷烷甲酰乙胺、苯氧乙醇、乙基己基甘油充分搅拌溶解,静置待用;
步骤二)第二次搅拌:按设定配比将B相原料:1,2-己二醇、辛酰羟肟酸、甘油辛酸酯、甘油、水、苯氧乙醇、乙基己基甘油充分搅拌溶解,静置待用;
步骤三)第三次搅拌:按设定配比将C相原料:将库拉索芦荟叶提取物、芍药根提取物、透明质酸钠、二裂酵母发酵产物溶孢物、密罗木叶提取物、烟酰胺、红景天提取物充分搅拌溶解,静置待用;
步骤四)第四次搅拌:按设定配比将D相原料:聚甲基硅倍半氧烷、乙烯基聚二甲基硅氧烷/聚甲基硅氧烷硅倍半氧烷交联聚合物、甲硅烷基化硅石、硅石、聚甲基硅氧烷搅拌均匀,将第一次、第二次和第三次搅拌的混合料体加入进行混合,进行第五次高速搅拌;
步骤五)将混合好的粉料,放入料桶内,做好标示粉料存储间内,开启紫外线进行消毒灭菌储存,时间5-6小时。
在此生产过程中,关键在制作方法步骤中加入次序、混合方式和工艺参数一定要按步骤走,不然产品会出现不稳定或者粘度、肤感的改变。根据各相组分的粘度,和搅拌温度要求,使得组分充分搅匀,不会造成组分分层不融合的现象。经过多次试验对比,不断调试,才能保证各项组分混匀。
在步骤一)中,所述A相原料需要加热至85℃后,以1000转/分钟进行充分搅拌至完全溶解,,然后冷却至室温静置待用。
在步骤二)中,所述B相原料以1000转/分钟混合搅拌至完全溶解,成透明状态。
在步骤三)中,述C相原料以1000转/分钟搅拌2分钟,搅拌至完全溶解。
在步骤五)中,第五次高速搅拌的时间为3-5秒,次数为2次,转速1000-3000转/分。
一、甘油
甘油为无色无味粘稠液体,英文名称:GLYCEROL,CAS号:56-81-5,分子式:C3H8O3,分子量:92.09,甘油特性是吸水性强(1克的甘油可吸附0.6克的水),因此甘油可以吸取空气中的水分给皮肤保湿,也能将皮肤中的水分锁住,将水分留在角质层,,同时甘油可以和多种物质相容,且混合良好,具有抗氧化性,因此可在各种护肤品中用作基料、润肤剂、保湿剂、润滑剂和溶剂。
二、丙二醇
丙二醇无色粘稠稳定的吸水性液体,分子式:CH2OHCHOHCH3(C3H8O2),分子量:76.10,英文名称:Propylene glycol,CAS号:57-55-6,丙二醇具有脂溶性溶剂的特性,为化妆品中常见之亲水保湿成份,真正功效为协助溶解污垢、避免卸妆过程中皮肤太快干燥。
三、二裂酵母发酵产物溶孢物
二裂酵母发酵产物溶孢物是经双歧杆菌培养、灭活及分解得到代谢产物、细胞质片段、细胞壁组分及多糖复合体,CAS号:96507-89-0,具有很强的抗免疫抑制活性并能促进DNA修复,可有效保护皮肤,不受紫外线引起的损伤,用于乳化、水基及水醇体系的护肤、防晒及晒后护理产品,帮助预防表皮及真皮的光老化。二裂酵母发酵产物溶孢物,会产生包括维他命B群、矿物质、氨基酸等有益护肤的小分子,是一种只用于护肤的优质酵母精华。其可以加强角质层的代谢,还能捕获自由基,抑制脂质的过氧化,具有美白、抗衰老的功能。
四、1,2-己二醇
1,2-己二醇为无色液态,英文名称:DL-1,2-Hexanediol,CAS号:6920-22-5,分子式:C6H14O2,分子量:118.1742,具有极高的吸湿性和保水性,是化妆品中最常用的保湿剂,同时具有降低微生物的水活度并抑制微生物的生长,是良好的抗菌防腐剂。
五、辛酰羟肟酸
辛酰羟肟酸,CAS No号:7377-03-9,分子式:C8H17NO2,分子量:159.22608,是一种抑菌的理想有机酸。对二价铁离子和三价铁离子有高效选择性的螯合能力,在铁离子受限的环境中,抑制霉菌的生长,同时具有能促进细胞膜结构降解的最佳碳链长度。因此具有较强的抗菌能力,是新型的防腐剂的替代物质。
六、库拉索芦荟叶提取物
库拉索芦荟叶提取物,英文名称是ALOE BARBADENSIS LEAF EXTRACT,库拉索芦荟叶提取物在化妆品、护肤品里主要作用是抗氧化剂,控油抗脂溢,抗炎剂,具有多方面的生物活性,是化妆品重要的添加剂。对纤维蛋白增长的促进作用、对弹性蛋白的抑制、对胶原蛋白的合成以及对自由基的清除作用,具有很好的活肤、抗老化在作用;对胆甾醇合成有促进作用,有助于改变皮脂的组成,减少油光和增加皮肤的柔润程度;同时具有抗菌消炎和保湿的作用。也用作皮肤晒黑剂。
七、芍药根提取物
芍药根提取物有效成分为芍药苷,对某些致病性细菌和真菌有抑制作用。芍药提取物对弹性蛋白酶的抑制、对自由基的消除、对氮氧化物生成的抑制以及对组织蛋白酶活性的促进等,均显示芍药提取物具有活肤抗衰的功能,可用于抗衰老化妆品。并且有比较好的保湿能力。
八、烟酰胺
烟酰胺为白色的结晶性粉末,CAS号:98-92-0,分子式:C6H6N2O,烟酰胺能够加速皮肤新陈代谢,加速含有黑色素细胞的角质脱落。烟酰胺的分子量小,可以直接被表皮细胞吸收,激发一些已经衰微的细胞活力,促进胶原蛋白的合成,防止黑色素过度沉着,达到美白的效果,同时还可以减少皮肤分泌的皮脂中脂肪酸和甘油三酯的产生,达到控制油脂分泌的效果,油脂分泌减少,皮肤排泄皮脂的管道毛孔也会慢慢缩小,达到缩小毛孔的目的。
与现有技术相比,本发明通过添加水、甘油、1,2-己二醇、辛酰羟肟酸、甘油辛酸酯,来改善现有散粉比较干燥的缺陷,提高了保湿功效,令定妆更自然、透明和柔和。
实施例1,所述一种爆水散粉,其包括以下组分(按重量份计):
一种爆水散粉的制备方法,其包括以下步骤:
步骤一)第一次搅拌,按设定配比将A相原料:水、甘油、丙二醇、薄荷酮甘油缩酮、甲基二异丙基丙酰胺、薄荷烷甲酰乙胺、苯氧乙醇、乙基己基甘油充分搅拌溶解,静置待用;
步骤二)第二次搅拌:按设定配比将B相原料:1,2-己二醇、辛酰羟肟酸、甘油辛酸酯、甘油、水、苯氧乙醇、乙基己基甘油充分搅拌溶解,静置待用;
步骤三)第三次搅拌:按设定配比将C相原料:将库拉索芦荟叶提取物、芍药根提取物、透明质酸钠、二裂酵母发酵产物溶孢物、密罗木叶提取物、烟酰胺、红景天提取物充分搅拌溶解,静置待用;
步骤四)第四次搅拌:按设定配比将D相原料:聚甲基硅倍半氧烷、乙烯基聚二甲基硅氧烷/聚甲基硅氧烷硅倍半氧烷交联聚合物、甲硅烷基化硅石、硅石、聚甲基硅氧烷搅拌均匀,将第一次、第二次和第三次搅拌的混合料体加入进行混合,进行第五次高速搅拌;
步骤五)将混合好的粉料,放入料桶内,做好标示粉料存储间内,开启紫外线进行消毒灭菌储存,时间5-6小时。
在此生产过程中,关键在制作方法步骤中加入次序、混合方式和工艺参数一定要按步骤走,不然产品会出现不稳定或者粘度、肤感的改变。根据各相组分的粘度,和搅拌温度要求,使得组分充分搅匀,不会造成组分分层不融合的现象。经过多次试验对比,不断调试,才能保证各项组分混匀。
在步骤一)中,所述A相原料需要加热至85℃后,以1000转/分钟进行充分搅拌至完全溶解,,然后冷却至室温静置待用。
在步骤二)中,所述B相原料以1000转/分钟混合搅拌至完全溶解,成透明状态。
在步骤三)中,述C相原料以1000转/分钟搅拌2分钟,搅拌至完全溶解。在步骤五)中,第五次高速搅拌的时间为3-5秒,次数为2次,转速1000-3000转/分。
实施例2,所述一种爆水散粉,其包括以下组分(按重量份计):
实施例3,所述一种爆水散粉,其包括以下组分(按重量份计):
根据上面所述步骤,进行比对实验,检测不同成分爆水散粉对皮肤的影响,提供了三组不同配比(按重量百分比)的爆水散粉和常规散粉做实验对比。
对比实验一:按实施例一配比制得爆水散粉为I
对比实验二:按实施例二配比制得爆水散粉为II
对比实验三:按实施例三配比制得爆水散粉为III
对比实验四:常规散粉为IV
实施例一,爆水散粉I,其包括以下组分(按重量份计):
一种爆水散粉的制备方法,其包括以下步骤:
步骤一)第一次搅拌,按设定配比将A相原料:水、甘油、丙二醇、薄荷酮甘油缩酮、甲基二异丙基丙酰胺、薄荷烷甲酰乙胺、苯氧乙醇、乙基己基甘油充分搅拌溶解,静置待用;
步骤二)第二次搅拌:按设定配比将B相原料:1,2-己二醇、辛酰羟肟酸、甘油辛酸酯、甘油、水、苯氧乙醇、乙基己基甘油充分搅拌溶解,静置待用;
步骤三)第三次搅拌:按设定配比将C相原料:将库拉索芦荟叶提取物、芍药根提取物、透明质酸钠、二裂酵母发酵产物溶孢物、密罗木叶提取物、烟酰胺、红景天提取物充分搅拌溶解,静置待用;
步骤四)第四次搅拌:按设定配比将D相原料:聚甲基硅倍半氧烷、乙烯基聚二甲基硅氧烷/聚甲基硅氧烷硅倍半氧烷交联聚合物、甲硅烷基化硅石、硅石、聚甲基硅氧烷搅拌均匀,将第一次、第二次和第三次搅拌的混合料体加入进行混合,进行第五次高速搅拌;
步骤五)将混合好的粉料,放入料桶内,做好标示粉料存储间内,开启紫外线进行消毒灭菌储存,时间5-6小时。
在步骤一)中,所述A相原料需要加热至85℃后,以1000转/分钟进行充分搅拌至完全溶解,,然后冷却至室温静置待用。
在步骤二)中,所述B相原料以1000转/分钟混合搅拌至完全溶解,成透明状态。
在步骤三)中,述C相原料以1000转/分钟搅拌2分钟,搅拌至完全溶解。在步骤五)中,第五次高速搅拌的时间为3-5秒,次数为2次,转速1000-3000转/分。
实施例二,爆水散粉II
一种爆水散粉,其包括以下组分(按重量份计):
一种爆水散粉的制备方法,其包括以下步骤:
步骤一)第一次搅拌,按设定配比将A相原料:水、甘油、丙二醇、薄荷酮甘油缩酮、甲基二异丙基丙酰胺、薄荷烷甲酰乙胺、苯氧乙醇、乙基己基甘油充分搅拌溶解,静置待用;
步骤二)第二次搅拌:按设定配比将B相原料:1,2-己二醇、辛酰羟肟酸、甘油辛酸酯、甘油、水、苯氧乙醇、乙基己基甘油充分搅拌溶解,静置待用;
步骤三)第三次搅拌:按设定配比将C相原料:将库拉索芦荟叶提取物、芍药根提取物、透明质酸钠、二裂酵母发酵产物溶孢物、密罗木叶提取物、烟酰胺、红景天提取物充分搅拌溶解,静置待用;
步骤四)第四次搅拌:按设定配比将D相原料:聚甲基硅倍半氧烷、乙烯基聚二甲基硅氧烷/聚甲基硅氧烷硅倍半氧烷交联聚合物、甲硅烷基化硅石、硅石、聚甲基硅氧烷搅拌均匀,将第一次、第二次和第三次搅拌的混合料体加入进行混合,进行第五次高速搅拌;
步骤五)将混合好的粉料,放入料桶内,做好标示粉料存储间内,开启紫外线进行消毒灭菌储存,时间5-6小时。
在步骤一)中,所述A相原料需要加热至85℃后,以1000转/分钟进行充分搅拌至完全溶解,,然后冷却至室温静置待用。
在步骤二)中,所述B相原料以1000转/分钟混合搅拌至完全溶解,成透明状态。
在步骤三)中,述C相原料以1000转/分钟搅拌2分钟,搅拌至完全溶解。在步骤五)中,第五次高速搅拌的时间为3-5秒,次数为2次,转速1000-3000转/分。
实施例三,爆水散粉III
一种爆水散粉,其包括以下组分(按重量份计):
一种爆水散粉的制备方法,其包括以下步骤:
步骤一)第一次搅拌,按设定配比将A相原料:水、甘油、丙二醇、薄荷酮甘油缩酮、甲基二异丙基丙酰胺、薄荷烷甲酰乙胺、苯氧乙醇、乙基己基甘油充分搅拌溶解,静置待用;
步骤二)第二次搅拌:按设定配比将B相原料:1,2-己二醇、辛酰羟肟酸、甘油辛酸酯、甘油、水、苯氧乙醇、乙基己基甘油充分搅拌溶解,静置待用;
步骤三)第三次搅拌:按设定配比将C相原料:将库拉索芦荟叶提取物、芍药根提取物、透明质酸钠、二裂酵母发酵产物溶孢物、密罗木叶提取物、烟酰胺、红景天提取物充分搅拌溶解,静置待用;
步骤四)第四次搅拌:按设定配比将D相原料:聚甲基硅倍半氧烷、乙烯基聚二甲基硅氧烷/聚甲基硅氧烷硅倍半氧烷交联聚合物、甲硅烷基化硅石、硅石、聚甲基硅氧烷搅拌均匀,将第一次、第二次和第三次搅拌的混合料体加入进行混合,进行第五次高速搅拌;
步骤五)将混合好的粉料,放入料桶内,做好标示粉料存储间内,开启紫外线进行消毒灭菌储存,时间5-6小时。
在步骤一)中,所述A相原料需要加热至85℃后,以1000转/分钟进行充分搅拌至完全溶解,,然后冷却至室温静置待用。
在步骤二)中,所述B相原料以1000转/分钟混合搅拌至完全溶解,成透明状态。
在步骤三)中,述C相原料以1000转/分钟搅拌2分钟,搅拌至完全溶解。在步骤五)中,第五次高速搅拌的时间为3-5秒,次数为2次,转速1000-3000转/分。
实验方法:选30位18-45岁不同年龄阶段的女性志愿测试者,分别使用三种不同爆水散粉和普通散粉,对试用后的定妆效果、保湿效果和肌肤护理效果进行评测,评分为1-5分,分数越高效果越好,计算全部志愿者的平均得分。
实验得分:
对定妆效果、锁水和保湿效果选取使用后3小时和6小时的效果评分。
效果测试(得分) | 细腻柔和 | 美白效果 | 抗皱效果 |
爆水散粉I | 4.5 | 4.2 | 4.0 |
爆水散粉II | 4.6 | 4.0 | 4.1 |
爆水散粉III | 4.5 | 4.1 | 4.3 |
普通散粉IV | 4.1 | 3.5 | 3.2 |
实验结论:三种不同配方的爆水散粉涂抹后皮肤感觉细腻柔和性好,在定妆效果上与普通散粉几乎一致,定妆持久度也非常好,锁水和保湿效果较普通散粉强,在美白肌肤和抗皱上也有很好效果,解决了普通散粉无护肤功效的缺陷,达到了研制本发明的目的。
以上已将本发明做一详细说明,以上所述,仅为本发明之较佳实施例而已,当不能限定本发明实施范围,即凡依本申请范围所作均等变化与修饰,皆应仍属本发明涵盖范围内。
Claims (9)
5.一种爆水散粉的制备方法,其特征在于包括以下步骤:
步骤一)第一次搅拌,按设定配比将A相原料:水、甘油、丙二醇、薄荷酮甘油缩酮、甲基二异丙基丙酰胺、薄荷烷甲酰乙胺、苯氧乙醇、乙基己基甘油充分搅拌溶解,静置待用;
步骤二)第二次搅拌:按设定配比将B相原料:1,2-己二醇、辛酰羟肟酸、甘油辛酸酯、甘油、水、苯氧乙醇、乙基己基甘油充分搅拌溶解,静置待用;
步骤三)第三次搅拌:按设定配比将C相原料:将库拉索芦荟叶提取物、芍药根提取物、透明质酸钠、二裂酵母发酵产物溶孢物、密罗木叶提取物、烟酰胺、红景天提取物充分搅拌溶解,静置待用;
步骤四)第四次搅拌:按设定配比将D相原料:聚甲基硅倍半氧烷、乙烯基聚二甲基硅氧烷/聚甲基硅氧烷硅倍半氧烷交联聚合物、甲硅烷基化硅石、硅石、聚甲基硅氧烷搅拌均匀,将第一次、第二次和第三次搅拌的混合料体加入进行混合,进行第五次高速搅拌;
步骤五)将混合好的粉料,放入料桶内,做好标示粉料存储间内,开启紫外线进行消毒灭菌储存,时间5-6小时。
6.根据权利要求5所述的爆水散粉的制备方法,其特征在于:在步骤一)中,所述A相原料需要加热至85℃后,以1000转/分钟进行充分搅拌至完全溶解,,然后冷却至室温静置待用。
7.根据权利要求5所述的爆水散粉的制备方法,其特征在于:在步骤二)中,所述B相原料以1000转/分钟混合搅拌至完全溶解,成透明状态。
8.根据权利要求5所述的爆水散粉的制备方法,其特征在于:在步骤三)中,所述C相原料以1000转/分钟搅拌2分钟,搅拌至完全溶解。
9.根据权利要求5所述的爆水散粉的制备方法,其特征在于:在步骤五)中,第五次高速搅拌的时间为3-5秒,次数为2次,转速1000-3000转/分。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011296342.4A CN112402335A (zh) | 2020-11-18 | 2020-11-18 | 一种爆水散粉及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011296342.4A CN112402335A (zh) | 2020-11-18 | 2020-11-18 | 一种爆水散粉及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112402335A true CN112402335A (zh) | 2021-02-26 |
Family
ID=74774661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011296342.4A Pending CN112402335A (zh) | 2020-11-18 | 2020-11-18 | 一种爆水散粉及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112402335A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113181067A (zh) * | 2021-05-24 | 2021-07-30 | 上海大喂科技发展有限公司 | 一种持久控油定妆散粉及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100183528A1 (en) * | 2008-12-17 | 2010-07-22 | Harmony Laboratories, Inc. | Acne treatment powder foundation |
CN105997545A (zh) * | 2016-06-30 | 2016-10-12 | 广州艾卓生物科技有限公司 | 含有甘油辛酸酯和辛酰羟肟酸的复配防腐剂及其制备方法 |
-
2020
- 2020-11-18 CN CN202011296342.4A patent/CN112402335A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100183528A1 (en) * | 2008-12-17 | 2010-07-22 | Harmony Laboratories, Inc. | Acne treatment powder foundation |
CN105997545A (zh) * | 2016-06-30 | 2016-10-12 | 广州艾卓生物科技有限公司 | 含有甘油辛酸酯和辛酰羟肟酸的复配防腐剂及其制备方法 |
Non-Patent Citations (3)
Title |
---|
国产非特殊用途化妆品备案信息服务平台: "自然堂冰肌爆水定妆散粉", 《HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=202005080928202E3J1&NID=202005080928202E3J1》 * |
国产非特殊用途化妆品备案信息服务平台: "臻爱蓝希源二裂酵母水感持妆粉底液", 《HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=20200727120324ESGSZ&NID=20200727120324ESGSZ》 * |
海淘族: "芙丽芳丝亮肤蜜粉成分表分析", 《HTTPS://WWW.KQMMM.COM/COSMETIC/101812.HTML》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113181067A (zh) * | 2021-05-24 | 2021-07-30 | 上海大喂科技发展有限公司 | 一种持久控油定妆散粉及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR102016017090A2 (pt) | aplicação tópica de composições para a pele tendo baixo ph | |
CN111840144B (zh) | 保湿修复组合物,其护肤品及制备方法 | |
CN107334726B (zh) | 一种祛痘组合物及其制备方法和应用 | |
CN110638707A (zh) | 一种眼部护理霜及其制备方法 | |
CN110664644B (zh) | 一种含叶酸的护肤组合物、精华及其制备方法 | |
CN110974767A (zh) | 用于皮肤屏障再生修复的组合物及其应用 | |
JP7366985B2 (ja) | 皮膚老化の徴候を処置する方法及び皮膚に潤いを与える方法 | |
CN110960458A (zh) | 一种保湿精华乳液及其制备方法 | |
CN113509400A (zh) | 皮肤用组合物及其应用、美白提亮化妆品组合物及其制备方法 | |
CN113116755A (zh) | 一种促渗透的护肤组合物及其制备方法和应用 | |
KR101895056B1 (ko) | 피부 보습 및 탄력 개선용 화장료 조성물 | |
CN113384482A (zh) | 一种保湿嫩肤精华露及其制备方法 | |
CN112402335A (zh) | 一种爆水散粉及其制备方法 | |
KR101605324B1 (ko) | 각질 제거 및 수분량 증가를 통한 건조 및 가려움 완화 효과를 가지는 보습용 화장료 조성물 | |
CN115400052B (zh) | 一种胭脂树红护肤沙霜及其制备方法 | |
CN109260086B (zh) | 一种抗皱精华液、制备方法及其应用 | |
CN111012699A (zh) | 一种含褐藻糖海带提取物的抗氧化控油乳液 | |
CN105919886A (zh) | 一种速效修复皱纹的乳液及其制备方法 | |
CN113893199B (zh) | 一种具有增加皮肤厚度功效的面霜组合物及其制备方法 | |
JP3895636B2 (ja) | 老化防止剤及びそれを用いた皮膚外用剤 | |
JP2015086160A (ja) | 保湿剤、肌荒れ改善剤、角層水分量増加剤、血流改善剤及び肌のくすみ、くま又はつや改善剤 | |
CN112137927A (zh) | 高渗透、重现光感初生肌的纤连蛋白精华乳及其制备方法 | |
CN112675063A (zh) | 一种含pdrn的嫩肤抗皱组合物及其应用 | |
CN112336675A (zh) | 一种无表面活性剂的养肤卸妆湿巾及其制备方法 | |
CN114053181A (zh) | 一种抗皱组合物及其在护肤品中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210226 |
|
RJ01 | Rejection of invention patent application after publication |